ClearView Healthcare Partners

What ClearView Healthcare Partners does

ClearView Healthcare Partners is an independent management consulting firm founded in 2007 that provides strategy advisory services exclusively to the life sciences industry. The firm serves biopharmaceutical and biotechnology companies, medical device and diagnostics manufacturers, life science services and tools companies, and life sciences investors across seven practice areas: Pharma & Biotech, Medtech & Diagnostics, Pricing & Market Access, Advanced Analytics, Launch & Commercialization, Expert Research Solutions, and Investor Support Services. ClearView operates as the largest independent strategy consulting firm focused in life sciences, with 251-500 employees across six global offices (Newton/MA headquarters, New York, San Francisco, London, Zurich, and Gurgaon, India), and is majority-owned by GHO Capital Partners since August 2021, with founding partners Rich Mynahan, Steve Chao, and Kevin Richard retaining material ownership.

The firm's core technology stack is its Advanced Analytics practice, which combines data science, machine learning, social network analysis, Bayesian modeling, and custom interactive visualizations to support client engagements. ClearView augments this with a strategic $4 million minority investment in Epistemic AI, integrating the EpistemicGPT biomedical knowledge graph (over 6 billion nodes and 20 billion connections) into its service offerings, with partner David McClain explicitly anchoring the firm's AI thesis. The firm does not sell a software product; it sells professional services engagements, typically staffed by 4-6 person teams over 4-6 weeks.

ClearView generates revenue through undisclosed professional services fees billed directly to enterprise and growth-stage life sciences clients, acquired via direct sales motion, conference relationships, and content-driven demand generation (gated white papers, the ClearView Convos podcast, and presence at ASH, ASCO, BIO, CPHI, JPM Healthcare, and ISPOR conferences). Pricing is not publicly disclosed; prospective clients are routed through a website contact form to initiate engagement. The firm markets its independence, deep scientific talent (many consultants hold PhDs in life sciences), and 15+ years of operating history as primary differentiators.

Name

ClearView Healthcare Partners

Legal name

ClearView Healthcare Partners, LLC

Website

http://clearviewhcp.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

251–500 employees

Short description

ClearView Healthcare Partners is an independent strategy consulting firm serving pharmaceutical, biotechnology, medtech, diagnostics, and life science investor clients through seven practice areas, with 251-500 employees across six global offices and AI-augmented analytics capabilities.

Ownership category

akta.pro rank

Headquarters

HQ city

Newton

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Strategy Consulting Services: ClearView generates revenue through billable consulting engagements with life sciences clients. The firm charges professional services fees for engagements across pharma & biotech strategy, medtech & diagnostics, pricing & market access, advanced analytics, launch & commercialization, expert research solutions, and investor support services. Typical project duration is approximately 4-6 weeks, with project teams of 4-6 people.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

ClearView Healthcare Partners is a life sciences strategy consulting firm that sells advisory engagements to pharmaceutical, biotechnology, medical device, diagnostic, life science services/tools, and life science investor clients. Engagements are delivered through seven practice areas — Pharma & Biotech, Medtech & Diagnostics, Pricing & Market Access, Advanced Analytics, Launch & Commercialization, Expert Research Solutions, and Investor Support Services — typically staffed by 4-6 consultants over 4-6 week project durations.

Product overview

ClearView Healthcare Partners is a life sciences strategy consulting firm that provides advisory services through multiple specialized practice areas. The firm's services are organized as consulting offerings rather than software products or modules. Core service areas include Pharma & Biotech strategy, Medtech & Diagnostics consulting, Pricing & Market Access advisory, Advanced Analytics, Launch & Commercialization support, Expert Research Solutions, and Investor Support Services. These consulting practices work collaboratively to support clients across the pharmaceutical, biotech, diagnostics, and medtech sectors with strategic decision-making throughout product development and commercialization cycles.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharma & Biotech Strategy Consulting Strategy consulting services for pharmaceutical and biotechnology companies supporting strategic decision-making, growth strategy at the product, franchise, or corporate level, clinical trial design, regulatory strategy, and market access across the drug development and commercialization lifecycle.
• Medtech & Diagnostics Consulting Commercial strategy, pricing and market access, value and evidence development, and launch support services for medical device and diagnostic companies navigating transformative P&MA and reimbursement trends.
• Pricing & Market Access Advisory Payer strategy, rebate negotiation, PBM engagement, formulary positioning, and pricing and market access advisory at product, franchise, and corporate levels for life sciences clients.
• Advanced Analytics Consulting Data science, machine learning, network analysis, Bayesian modeling, and custom interactive visualizations applied to revenue forecasting, physician targeting, patient finding, KOL identification, and promotional response modeling for life sciences clients.
• Launch & Commercialization Consulting Market understanding, capability building, launch strategy development, launch execution, and post-launch performance optimization for life sciences clients across therapeutic areas.
• Expert Research Solutions Primary research and expert engagement services for life sciences clients seeking differentiated insights through expert interviews, KOL consultations, and tailored research support.
• Investor Support Services Due diligence, target identification, portfolio company strategy, exit planning, and buy-side and sell-side engagements for biopharma, diagnostics, life science services, and life science tools investors.

Named customers5 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Epistemic AIcoreStrategic or Co-development Partner · 10 January 2025ClearView made a strategic $4,000,000 minority investment in Epistemic AI, a pioneer in enterprise-grade AI solutions for biomedical research. The partnership integrates Epistemic AI's EpistemicGPT knowledge discovery platform (with over 6 billion nodes and 20 billion connections) across ClearView's service offerings to enhance analytical tasks, drive efficiency, and provide more rapid actionable insights for biopharma clients. ClearView will help shape future iterations of the Epistemic AI platform.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Trinity Partners: Trinity Partners is a life sciences-focused strategy consulting firm serving biotech, pharma, and medtech clients with commercial strategy, market access, and portfolio advisory services. It is a direct peer given comparable size, specialist life sciences positioning, and overlapping service offerings in pricing, market access, and launch commercialization.
• Prescient Healthcare Group: Prescient Healthcare Group is a specialist life sciences strategy and competitive intelligence consulting firm serving biopharma and medtech clients. It is a direct peer, with ClearView COO Sidnee Pinho having previously served as Prescient's COO, and both firms competing for similar commercial strategy and pipeline advisory mandates.
• Lumanity: Lumanity is a life sciences consulting firm formed from the merger of several specialist consultancies, providing commercial strategy, medical affairs, and market access services to biopharma. It is a direct peer given similar specialist positioning and growing scale, with overlap in pricing, market access, and launch commercialization engagements.
• CBPartners: CBPartners is a specialist pricing, market access, and evidence strategy consulting firm serving pharmaceutical and biotechnology clients globally. It is a direct peer given a near-identical pricing and market access focus and similar biopharma client base, with comparable expertise in payer strategy, formulary positioning, and value communication.
• Charles River Associates (CRA): Charles River Associates operates a Life Sciences practice that provides strategy consulting to biopharma, biotech, and medtech clients globally. It is a direct peer given that multiple ClearView senior leaders (Mike Roy, Ryan Tubman) were recruited from CRA's life sciences analytics group, and both firms compete for the same enterprise life sciences strategy mandates.
• Health Advances: Health Advances is a strategy consulting firm focused exclusively on the life sciences industry, serving biopharma, medtech, diagnostics, and investor clients with commercial strategy and transaction support. It is a direct peer with a comparable specialist positioning and similar service portfolio to ClearView's pharma/biotech and medtech/diagnostics practices.
• SmartAnalyst: SmartAnalyst is a specialist consulting firm focused on pricing, market access, and value/evidence strategy for biopharmaceutical companies. It is a direct peer with strong overlap with ClearView's Pricing & Market Access practice, serving similar pharma/biotech clients with comparable payer strategy, evidence development, and reimbursement advisory work.

Broad incumbents

• IQVIA: IQVIA is a global life sciences technology, analytics, and consulting provider with a large consulting practice serving biopharma and biotech clients. It is a broad incumbent peer given significantly larger scale, data assets, and overlapping capabilities in commercial strategy, market access, and advanced analytics for life sciences.
• Huron Consulting Group (Life Sciences): Huron is a large diversified professional services firm with a dedicated Life Sciences strategy consulting practice (formerly the Frankel Group). It is a broad incumbent peer because ClearView's COO Sidnee Pinho and Partner David Gilman both previously served in Huron's life sciences leadership, and Huron competes for similar biopharma strategy engagements at larger scale.
• ZS Associates: ZS Associates is a large global management consulting firm with a deep life sciences practice spanning commercial strategy, pricing, market access, and advanced analytics. It is a broad incumbent peer given significantly larger scale and overlap with ClearView's pricing/market access and advanced analytics practices.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/clearviewhcp
• LinkedInlinkedin.com/company/clearview-healthcare-partners

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ClearView Healthcare Partners